April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Vitrectomy and Internal Limiting Membrane Peeling for Vitreomacular Traction Syndrome With or Without Indocyanine Green Staining
Author Affiliations & Notes
  • A. J. Barkmeier
    Ophthalmology, Baylor COM / Cullen Eye Institute, Houston, Texas
  • M. J. Ko
    Ophthalmology, Baylor COM / Cullen Eye Institute, Houston, Texas
    Ophthalmology, Stanford School of Medicine, Stanford, California
  • P. E. Carvounis
    Ophthalmology, Baylor COM / Cullen Eye Institute, Houston, Texas
  • J. L. Heffez
    Ophthalmology, Baylor COM / Cullen Eye Institute, Houston, Texas
  • E. R. Holz
    Ophthalmology, Baylor COM / Cullen Eye Institute, Houston, Texas
  • Footnotes
    Commercial Relationships  A.J. Barkmeier, None; M.J. Ko, None; P.E. Carvounis, None; J.L. Heffez, None; E.R. Holz, None.
  • Footnotes
    Support  Research to Prevent Blindness unrestricted educational grant
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 4439. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. J. Barkmeier, M. J. Ko, P. E. Carvounis, J. L. Heffez, E. R. Holz; Vitrectomy and Internal Limiting Membrane Peeling for Vitreomacular Traction Syndrome With or Without Indocyanine Green Staining. Invest. Ophthalmol. Vis. Sci. 2009;50(13):4439.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To compare functional results after vitrectomy and internal limiting membrane (ILM) peeling for vitreomacular traction syndrome (VMT) with or without indocyanine green (ICG) staining.

Methods: : Retrospective, interventional, consecutive case series. Included were 29 eyes of 27 consecutive patients who underwent vitrectomy with internal limiting membrane peeling for vitreomacular traction at a single institution from 1998 - 2006. Patient demographics, medical and ocular history, and clinical data were recorded.

Results: : Mean pre-operative vision was 20/104 (logMAR 0.71), improving post-operatively to 20/59 at 1-3 months (logMAR 0.47, p=0.002), 20/49 at 3-6 months (logMAR 0.39, p<0.0001), 20/48 at one year (logMAR 0.38, p<0.0001), 20/48 at last follow-up (logMAR 0.38, p<0.0001), and 20/37 for the best post-operative acuity (logMAR 0.27, P<0.0001). Mean follow-up was 26.6 +/- 20.8 months. Pre- and post-operative OCT data were available for 8 eyes and demonstrated post-operative macular thinning from 559 +/- 239 to 219 +/- 72 microns (change of 340 +/- 229 microns, p=0.005). ICG staining was employed in 12 of 29 eyes. Mean pre-operative vision for eyes after ILM-peeling with and without the use of ICG was 20/124 and 20/92 (logMAR 0.79 and 0.66), improving to 20/49 and 20/59 at 1-3 months (logMAR 0.39 and 0.47), 20/47 and 20/51 at 3-6 months (logMAR 0.37 and 0.40), 20/41 and 20/53 at one year (logMAR 0.31 and 0.42), 20/42 and 20/53 at last follow-up (logMAR 0.33 and 0.42), and 20/36 and 20/40 for the best post-operative acuity (logMAR 0.26 and 0.31), respectively. Intergroup differences were statistically significant in favor of ICG-assisted ILM peeling at the one year (p=0.046) and final visits (p=0.039), but not for the early or best follow-up visits.

Conclusions: : Excellent functional outcomes can be achieved with vitrectomy and ILM peeling for vitreomacular traction syndrome. No adverse outcomes clearly attributable to ICG were identified, and patient eyes in which ICG was employed for ILM peeling trended toward improved visual outcomes.

Keywords: vitreoretinal surgery • macula/fovea • vitreous 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×